NONTRANSPLANT CARDIAC SURGERY FOR END-STAGE CARDIOMYOPATHY  by Suma, Hisayoshi et al.
Objective: To treat end-stage cardiomyopathy, we evaluated endoventricular
circular patch plasty, partial left ventriculectomy, and valvular reconstruction
alone in our 2-year experience. 
Methods: Among 86 patients with heart failure evaluated between December
1996 and February 1999, 33 patients with ischemic cardiomyopathy (25 men
and 8 women; mean age 61 ± 7.8 years; New York Heart Association class
3.5 ± 0.5) were treated with endoventricular circular patch plasty combined
with coronary bypass grafting (84%) and mitral reconstruction (36%). The
other 53 patients with nonischemic cardiomyopathy (45 men and 8 women;
mean age 48 ± 14.3 years, New York Heart Association class 3.7 ± 0.5), were
treated by left ventricular reduction by partial left ventriculectomy (n = 37)
or patch plasty (n = 3) and valve reconstruction alone (n = 13). The first 24
patients (group I) underwent ventriculectomy with or without valve recon-
struction; the more recent 29 patients (group II) underwent left ventricular
reduction (n = 16) or valve reconstruction alone (n = 13) on the basis of the
intraoperative echocardiographic evaluation to observe changes of wall
motion and thickness during cardiopulmonary bypass. 
Results: Ischemic group: Hospital mortality in elective (n = 26) and emer-
gency (n = 7) operations was 4% and 43%, and 3 patients died in the late
postoperative period. Mean New York Heart Association class and ejection
fraction improved from 3.5 ± 0.5 to 1.5 ± 0.7 and from 23% ± 7.7% to 36%
± 8.6%, respectively. Left ventricular end-diastolic and end-systolic volume
indexes decreased from 162 ± 46 mL/m2 to 110 ± 39 mL/m2 and from 130
± 47 mL/m2 to 70 ± 32 mL/m2, respectively. Nonischemic group: In 40
patients with left ventricular reduction, hospital mortality in elective (n = 33)
and emergency (n = 7) operations was 6% and 86%, and 5 patients died in
the late postoperative period. Mean New York Heart Association class and
ejection fraction improved from 3.7 ± 0.5 to 1.7 ± 0.6 and from 18% ± 6.4%
to 31% ± 5.9%. Left ventricular end-diastolic and end-systolic volume
indexes decreased from 203 ± 45 mL/m2 to 110 ± 37 mL/m2 and from 164
± 40 mL/m2 to 79 ± 33 mL/m2, respectively. In 13 patients undergoing valve
reconstruction alone (12 mitral with or without tricuspid and 1 tricuspid plus
left ventricular assist device), hospital mortality in elective (n = 9) and emer-
gency (n = 4) operations was 0% and 50% with no late deaths. Mean New
York Heart Association class and ejection fraction improved from 3.6 ± 0.5
to 2.0 ± 0.5 and from 22% ± 6.0% to 30% ± 14.5%, respectively. Mean left
ventricular end-diastolic and end-systolic volume indexes decreased from
170 ± 34 mL/m2 to 150 ± 50 mL/m2 and from 140 ± 38 mL/m2 to 104 ± 40
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C ardiac transplantation is an established treatmentfor end-stage heart failure. However, it is not wide-
ly available because of a shortage of donors and, in
parts of the world, societal limitations. In the search for
an effective nontransplant cardiac operation to treat
end-stage cardiomyopathy, partial left ventriculectomy
(PLV),1,2 endoventricular circular patch plasty
(EVCPP),3 and mitral annuloplasty alone4 have recent-
ly been clinically investigated. We report our 2-year
experience with these procedures.
Patients and methods
From December 1996 to February 1999, 86 patients (70
men and 16 women, mean age 54 years, range 14-79 years)
with ischemic and nonischemic dilated cardiomyopathy were
surgically treated at Shonan Kamakura General Hospital. All
patients had signs of New York Heart Association (NYHA)
class III or IV heart failure with a dilated, poorly functioning
left ventricle. Sixty-seven (78%) patients of them were con-
sidered to be candidates for heart transplantation, and 46 in
the 67 patients were either more than 70 years old or had
severe pulmonary hypertension before the operation.
Ischemic cardiomyopathy group. Ischemic cardiomyopa-
thy was defined as a nonaneurysmal, diffusely akinetic left
ventricle with chronic heart failure after myocardial infarc-
tion. Among 58 patients undergoing EVCPP for postinfarc-
tion left ventricular dysfunction in the same period, we
enrolled 33 patients in the ischemic cardiomyopathy group by
excluding those with a dyskinetic or akinetic left ventricle
with large scar clearly bordered with well-functioning
myocardium.
The group comprised 25 men and 8 women with a mean
age of 61 years, ranging from 48 to 79 years. All patients
had signs of congestive heart failure—NYHA class III in
17 patients and class IV in 16 patients. Six patients had
mild angina pectoris before the operation but the others did
not have chest pain. Among 16 patients in NYHA class IV,
7 required inotropic support (status 1). Seven patients had
ongoing shock and required emergency surgery. All
patients had a large anteroseptal myocardial infarction with
or without a posterolateral or inferior infarction. Coronary
angiography showed single vessel disease (anterior
descending artery) in 2 patients, double vessel disease in 7
patients, triple vessel disease in 20 patients, and left main
trunk disease with a distal coronary artery lesion in 4
patients. Mitral regurgitation was noted in 12 patients
(36%) and tricuspid regurgitation in 4 patients.
Preoperative characteristics of the patients and their left
ventricles are summarized in Table I and Fig 1.
Surgical technique. During normothermic cardiopul-
monary bypass (CPB) with antegrade warm blood cardio-
plegia, coronary artery bypass grafting (CABG) or mitral
repair was performed first and then the left ventricle was
opened. While observing the left ventricle closely, we
placed an endocardial 2-0 Prolene purse-string suture
(Ethicon, Inc, Somerville, NJ) along the border between
the akinetic and kinetic areas, as Dor described.5 The bor-
der between the akinetic and kinetic areas was sometimes
difficult to define because there is no clear scar in the left
ventricle in ischemic cardiomyopathy. We assessed it by
palpation of the left ventricle with the open beating heart
technique by aortic declamping. The purse-string suture
was pulled and tied, and then the remaining opening was
closed with a Dacron patch attached with a continuous 2-0
Prolene suture. Finally, the excluded akinetic left ventricu-
lar wall was closed to avoid postoperative bleeding (Fig 2).
CABG was performed in 31 patients (94%) with a mean
number of 3.1 ± 1.2 distal anastomoses per patient. The ante-
rior descending artery was graftable in 26 patients, although
it was not clearly visualized in preoperative angiograms in
many cases. A mitral valve operation was concomitantly per-
formed in 12 patients, with 8 valve repairs and 4 replace-
ments. Tricuspid annuloplasty was added in 4 patients. The
mean durations of aortic crossclamping and CPB were 75 ±
36 minutes and 135 ± 54 minutes, respectively.
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mL/m2, respectively. Overall mortality decreased from 50% in group I to
10% in group II. The survival estimates at 2 years were 77% (confidence
limits 57%-88%) in the ischemic group and 63% (confidence limits 47%-
75%) in the nonischemic group (no significant difference). The analysis of
our data showed that the factors influencing the surgical results for dilated
cardiomyopathy were presence of severe mitral regurgitation, preoperative
New York Heart Association functional class IV with emergency operation,
and operative procedures with randomly performed partial left ventriculec-
tomy without an intraoperative echo test. 
Conclusion: Endoventricular circular patch plasty, partial left ventriculecto-
my, and solo valve reconstruction can be performed with an acceptably low
risk as elective operations. The selection of operative procedures in idio-
pathic dilated cardiomyopathy and avoidance of emergency surgery
improved operative mortality and morbidity. Among patients who survived
at least 1 year, there were no late deaths up to 30 months’ follow-up. (J
Thorac Cardiovasc Surg 2000;119:1233-45)
Nonischemic cardiomyopathy group. This group com-
prised 53 patients (45 male and 8 female patients, mean age
49 ± 14 years, range 14-72 years) with NYHA class III  in 19
patients (36%) and class IV in 34 patients (64%). Mean dura-
tion of heart failure was 54 ± 37 months. Twenty-five patients
(47%) were supported by intravenous inotropic drugs and 2
patients required intra-aortic balloon pumping before the
operation. Eleven patients (20%) needed emergency surgery
because of severe pulmonary edema with hypotension in 8
and cardiac arrest in 3.
The etiology of cardiomyopathy was noted to be idiopath-
ic dilated cardiomyopathy in 41 patients (77%), dilated
hypertrophic cardiomyopathy in 2 patients, valvular in 7
patients, and arrhythmogenic right ventricular dysplasia, sar-
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Fig 1.  Changes in NYHA class and left ventricular parameters before and after the operation. EF, Ejection frac-
tion; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; NS, not significant; EVCPP, endoven-
tricular circular patch plasty; PLV, partial left ventriculectomy.
Table I.  Preoperative characteristics
Type of cardiomyopathy/type of procedure
Nonischemic
Ischemic Group I Group II
EVCPP ± CABG/valve LV reduction ± valve LV reduction Valve alone
No. of patients 33 24 16 13
Age (y) 61 (48-79) 48 (14-67) 48 (38-70) 51 (16-72)
P value — <.001* .001* .008*
NYHA III/IV (inotropic agents) 17/16 (7) 7/17 (14) 8/8 (6) 6/7 (5)
Ejection fraction (%) 22.6 ± 7.7 18.4 ± 6.7 16.9 ± 4.7 22.2 ± 6.0
P value — .02 .3 .9
Diastolic dimension (mm) 68.9 ± 10.3 77.0 ± 6.4 84.0 ± 8.8 75.1 ± 6.2
P value — <.001* <.001* .06
End-diastolic volume index (mL/m2) 161.8 ± 45.5 194.6 ± 40.8 216.6 ± 43.3 173.6 ± 34.3
P value — .001* <.001* .4
End-systolic volume index (mL/m2) 126.8 ± 47.2 158.3 ± 38.9 176.3 ± 34.4 135.7 ± 38.3
P value — <.001* <.001* .4
P value: Nonischemic group is compared with ischemic group. EVCPP, Endoventricular circular patch plasty; CABG, coronary artery bypass grafting; LV, left ven-
tricular; NYHA, New York Heart Association. 
coidosis, and corrected transposition of great arteries in 1
patient each. 
Regarding surgical strategy, we initially nonselectively per-
formed PLV with or without mitral valve reconstruction as a
primary choice in 24 consecutive patients (group I). Papillary
muscles were sometimes included for wide excision to
achieve strict downsizing of the left ventricle in this group.
Then we tried to find the proper site for excision to avoid
excessive ventriculectomy by introducing an intraoperative
echo-guided volume reduction test.
The basic concept of the volume reduction test is that
changes of left ventricular wall motion and thickness can be
seen by echocardiography (HP SONOS 5500, Hewlett-
Packard Company, Andover, Mass) before performing the
ventriculotomy when the left ventricle is decompressed during
CPB, because wall tension may decrease. By decompressing
the left ventricle, we could see that the akinetic part becomes
kinetic, that is, increased kinetic zones of colors, with
increased wall thickness. When a certain area stays thin and
akinetic under this condition, we decide to perform PLV or
EVCPP depending on the site of akinesis. On the other hand,
when the entire left ventricle becomes kinetic, we decide to
perform valve reconstruction alone without PLV (Fig 3).
In the latter 29 patients treated with this method (group II),
16 patients underwent left ventricular reduction and the other
13 patients underwent valvular reconstruction alone.
Preoperative characteristics of groups I and II are shown in
Table I.
In 37 (92%) of the 40 patients having left ventricular reduc-
tion (37 PLV and 3 EVCPP), a mitral valve operation was
also done, with 26 replacements and 11 repairs. Tricuspid
annuloplasty and aortic valve replacement were concomitant-
ly performed in 24 and 4 patients, respectively. Durations of
aortic crossclamping and CPB were 73 ± 30 minutes and 140
± 52 minutes, respectively. Amiodarone 200 mg was routine-
ly given after the operation unless adverse effects appeared.
In 13 patients who underwent valvular operations alone,
mitral valve surgery was done in 12 patients with 9 repairs
and 3 replacements, and tricuspid valve surgery was com-
bined in 7 patients. The maze procedure was added for 5
patients to treat atrial fibrillation. One patient who was in
profound shock was treated with a left ventricular assist
device and tricuspid valve replacement. Durations of aortic
crossclamping and CPB were 99 ± 27 minutes and 162 ± 29
minutes, respectively.
Surgical technique. During normothermic CPB, the initial
15 patients were operated on with antegrade warm blood car-
dioplegia for PLV and mitral valve replacement. After those
learning periods, the PLV was performed on the on-pump
beating heart without aortic crossclamping, while cardio-
plegic arrest was used for mitral annuloplasty with an under-
sized prosthetic ring through the left atriotomy. It is not nec-
essary to make an incision down to the base of the ventricle
to extend close to the mitral anulus for PLV. Placing deep and
wide mattress sutures (basal tack) without extending the inci-
sion is safe and effective (Fig 4). It is important not to leave
the dilated base without constriction to obtain effective ejec-
tion according to the basal band theory of Torrent-Guasp.6
The left ventricle was closed in 2 layers with large-needle 
2-0 monofilament sutures (Matsuda Ika Kogyo, Japan) with a
bovine strip or Teflon felt if necessary. Tricuspid regurgita-
tion was corrected with the De Vega annuloplasty.
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Fig 2. Scheme of endoventricular circular patch plasty (EVCPP). A, A left ventricular incision is made along the
anterior descending artery from the apex, and a purse-string suture is placed between the akinetic and kinetic areas.
B, The purse-string suture is pulled and tied. The remaining opening is closed with a Dacron patch. C, Finally, the
excluded left ventricular wall is closed to avoid bleeding.
Evaluation and follow-up. All patients had preoperative
evaluation by cardiac echocardiography. All except very
sick patients underwent magnetic resonance imaging,
emission beam tomography (Imatron, Inc, South San
Francisco, Calif), gated cardiac pool scan, and phase image
analysis to assess the left ventricular status before and after
the operation. A preoperative catheter ventriculogram was
taken when the patient was in relatively stable condition.
Dobutamine stress echocardiography was performed in 11
patients, and many others already had inotropic support.
Exercise thallium scintigraphy was performed in 18
patients with ischemic cardiomyopathy. A pathologic study
was performed in all patients who underwent PLV. A spec-
imen was taken from both the excised left ventricular wall
and the ventricular septum.
Follow-up studies were performed in all patients, and the
patients received detailed follow-up examinations including
cardiac catheterization every 6 months.
Statistical analysis. Continuous variables are expressed as
mean ± SD. Cumulative survivals were calculated by the
Kaplan-Meier estimation with the date of operation and the
date of most recent follow-up. The differences in the survival
were determined by log-rank analysis. A multivariable analy-
sis of independent factors was performed with the Cox pro-
portional hazard model analysis.
Results
Ischemic cardiomyopathy group. Of the 26
patients who underwent an elective operation, 1
patient (4%) died in the hospital of a stroke. Late
death after discharge from the hospital occurred in 3
patients as a result of arrhythmia, heart failure, and
stroke, respectively. Of 7 patients having an emer-
gency operation, 3 patients (43%) died of multiorgan
failure during hospitalization. No late deaths were
noted in this group. The 2-year survival was 77%
(95% confidence limits 57%-88%) (Fig 5). NYHA
class improved to class 1.5 ± 0.7. Left ventricular
end-diastolic or end-systolic volume indexes
decreased to 110 ± 39 mL/m2 or 70 ± 32 mL/m2,
respectively, and ejection fraction improved to 36% ±
8.6%, as shown in Fig 1. All parameters improved
significantly after the operation (P < .05) (Fig. 6).
Nonischemic cardiomyopathy group. In group I, 2
(12%) of 17 patients having an elective operation died
in the hospital, 1 of pneumonia and the other of heart
failure. On the other hand, 6 (86%) of 7 patients with
an emergency operation died during hospitalization of
heart failure, infection, valvular reoperation, and multi-
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Fig 3.  Intraoperative echo-guided volume reduction test used to choose the procedure. During cardiopulmonary
bypass (Post-CPB) with left ventricular decompression, when the left ventricle increases wall motion and thick-
ness, mitral valve reconstruction (MAP) alone without ventriculectomy is done (top). On the other hand, when an
akinetic area remains, partial left ventriculectomy (PLV) is performed (bottom).
organ failure. There were 5 late deaths caused by recur-
rent heart failure in 2 patients and hepatic failure, pros-
thetic valve thrombus, and pulmonary tuberculosis in 1
patient each. 
In group II, there were no deaths in 25 patients hav-
ing elective operations and 2 deaths, due to heart fail-
ure, in 4 patients having emergency operations. One
patient died in the late postoperative period of cancer
without heart failure.
Return of heart failure was noted in 4 patients in
group I, with 2 deaths, and in 5 patients in group II,
with no late deaths. One patient having mitral valve
repair alone as the initial operation returned to the hos-
pital with recurrent mitral regurgitation and an enlarged
left ventricle. The patient was then successfully treated
by mitral valve replacement and PLV (Table II). The
survival estimate was 63% (confidence limits 47%-
75%) at 2 years (Fig 5).
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Fig 4.  Scheme of partial left ventriculectomy. A, A lateral left ventricular incision is made including the apex. B,
Excision does not extend beyond papillary muscles. C, Instead of the incision down to the base close to the mitral
anulus, a deep and wide mattress suture (basal tack) is safe and effective. D, The ventriculotomy is closed in 2 lay-
ers with continuous sutures.
Fig 5.  Kaplan-Meier survival estimates. At 2 years, the survival estimate was 77% (confidence limits 57%-88%)
in patients with ischemic cardiomyopathy and 63% (confidence limits 47%-75%) in patients with nonischemic car-
diomyopathy after surgery.
A C
B D
To summarize the surgical results of left ventricular
reduction in nonischemic cardiomyopathy in 40 patients,
there were 2 hospital deaths in 33 elective operations and
6 hospital deaths in 7 emergency operations. Overall hos-
pital mortality was 20%, and 5 patients died in the late
postoperative period. One- and 2-year survivals were
61% in all cases, 71% in elective cases, and 14% in emer-
gency cases, and there were no deaths 1 year after the
operation.  NYHA class improved to class 1.7 ± 0.6. Left
ventricular end-diastolic or end-systolic indexes
decreased to 110 ± 37 mL/m2 or 79 ± 33 mL/m2, respec-
tively, and ejection fraction improved to 31.3% ± 5.9%,
as shown in Fig 1. All variables improved significantly
after the operation (P < .05) (Fig 7).
Changes of NYHA class and left ventricular parame-
ters are shown in Fig 1. Left ventricular end-diastolic
pressure and mean pulmonary capillary wedge pressure
decreased significantly from 28 ± 7.8 mm Hg to 21 ±
7.5 mm Hg and from 25 ± 7.6 mm Hg to 19 ± 8.3 mm
Hg, respectively, at 1 postoperative month in 20
patients. Once successful left ventricular reduction had
been accomplished, the histogram became close to nor-
mal with time (Fig 8). On the other hand, in patients
who had recurrent heart failure after the operation, the
histogram did not improve regardless of postoperative
left ventricular size (postoperative left ventricular
dimension ranged from 50 to 76 mm in 5 patients hav-
ing return of heart failure) (Fig 9).
Regarding ventricular arrhythmias, 33 patients
underwent 24 hours of Holter monitoring before and
after PLV. By Lown class assessment, 21 patients
(84%) were in class IV-b before the operation. The
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Table II.  Surgical results of left ventricular reduction
Group I Group II
EVCPP ± CABG/valve LV reduction ± valve LV reduction ± valve Valve alone
No. 33 24 16 13
Mortality 7/33 12/24 1/16 2/13
Hospital + late (%) 21.2 50.0 6.3 15.4
IABP/LVAD 1/0 6/0 0/0 1/1
Return of heart failure 3 4 3 2
Follow-up (d) 377 ± 228 365 ± 323 272 ± 109 316 ± 156
Median (d) 362 278 262 368
EVCPP, Endoventricular circular patch plasty; CABG, coronary artery bypass grafting; LV, left ventricular; IABP, intra-aortic balloon pumping; LVAD, left ventricu-
lar assist device.
Fig 6.  Magnetic resonance imaging ventriculogram before and after endoventricular circular patch plasty for
ischemic cardiomyopathy. Ejection fraction (EF) increased from 18% to 38% and left ventricular end-diastolic and
end-systolic indexes decreased from 194 to 101 mL/m2 and from 160 to 63 mL/m2, respectively. New York Heart
Association class improved from IV to I in a 64-year-old man.
condition of 14 patients (42%) improved, that of 17
patients (52%) remained unchanged, and that of 2
patients (6%) worsened. Eight patients were in class
I after the operation. Three patients died of
intractable heart failure with ventricular tachy-
arrhythmia, but no patients died of sudden arrhythmia
without heart failure. No implantable defibrillator
was used. According to Holter monitoring, 42% of
the patients had an improvement in NYHA class after
the operation, and ventricular arrhythmia improved
significantly (P < .0017).
According to the Cox proportional hazards model
analysis for hospital and late mortality, the factors
influencing the surgical results were severe mitral
regurgitation, preoperative NYHA functional class IV
with the need for emergency treatment, and a random-
ly performed PLV without intraoperative echocardiog-
raphy (P < .05), as summarized in Table III.
Discussion
Although medical treatment is advancing for heart
failure,7-9 many patients are still awaiting cardiac trans-
plantation. As physicians try to find an effective non-
transplant cardiac surgical procedure, PLV,1,2,10-13
EVCPP,3 cardiomyoplasty,14,15 and the ventricular
assist device16-18 have been applied clinically, in addi-
tion to valvular reconstruction or CABG.
Whereas Batista and colleagues1 have applied PLV
for ischemic cardiomyopathy, we prefer EVCPP.
Exclusion of akinetic septum, which is frequently asso-
ciated with ischemic cardiomyopathy caused by occlu-
sion of the large anterior descending artery, is easy and
effective with the use of the purse-string suture tech-
nique described by Fontan.19 Dreyfus and colleagues20
have shown that CABG alone is effective in a certain
group of patients assessed by positron emission tomog-
raphy and several preoperative examinations. However,
Yamaguchi and associates21 performed CABG alone in
41 patients with an ischemic dilated heart. They sug-
gested that the preoperative left ventricular end-systolic
volume index predicted the development of postopera-
tive congestive heart failure and actuarial survival in
patients with ischemic cardiomyopathy. In our series,
preoperative left ventricular viability was not always
fully evaluated because of the patient’s condition and
lack of a positron emission tomographic scan.
However, we believe that the combination of an
enlarged left ventricle, signs of heart failure, and
absence of angina pectoris are strong indicators of an
unsuccessful outcome by CABG alone.21 We think that
surgical restoration is an effective solution for a better
outcome.22
The surgical strategy for nonischemic cardiomyopa-
thy is more complicated. In the beginning, we thought
that the extent of myocardial damage was homoge-
neous in idiopathic cardiomyopathy; therefore, we sim-
ply followed Batista’s PLV to make the enlarged left
ventricle small. After our initial experiences looking
inside the left ventricle, we found that the area that was
supposed to have pronounced endocardial scarring did
not have macroscopic scars. This evidence was proven
by pathologic findings obtained from excised posterior
wall and remaining septum in the same heart in our
specimens. Therefore, we decided that it was important
to assess the left ventricular wall characteristics before
PLV to avoid excessive resection of a kinetic area.
Intraoperative evaluation by echocardiography was
found to be helpful for this purpose.
The next important problem was the return of
intractable heart failure, which probably was due to (1)
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Fig 7.  Magnetic resonance imaging ventriculogram before and after partial left ventriculectomy for idiopathic
dilated cardiomyopathy. Ejection fraction increased from 18% to 32% and left ventricular end-diastolic and end-
systolic indexes decreased from 198 to 105 mL/m2 and from 160 to 71 mL/m2, respectively. There are no instances
of redilatation at 1 and 2 years after the operation. New York Heart Association class improved from class IV with
inotropic agents to class I in a 58-year-old man.
recurrence of mitral regurgitation, (2) a remaining dilated
lesion of the left ventricle, (3) too small a left ventricle
due to excessive excision, and (4) removal of the kinetic
left ventricular wall without removal of lesions.
Prediction of the appropriate postoperative left ven-
tricular size is difficult because a proper size depends
on myocardial stiffness, and the stiffness is different in
each patient with cardiomyopathy.23,24 For example, a
postoperative left ventricular diameter below 6 cm is
good for a low-stiffness ventricle, but it is too tight for
a high-stiffness ventricle and easily results in a dia-
stolic disorder. Therefore, a theoretic model25,26 is dif-
ficult to devise as an experimental model to decide the
correct degree of left ventricular reduction.
After proper selection of operative procedures, hos-
pital mortality and morbidity and late death decreased
significantly. Because the kinetic left ventricular mus-
cle was left intact, the prevalence of congestive heart
failure lessened. When PLV was being performed non-
selectively, heart failure was caused by making the
heart too small or by excision of kinetic heart muscle.
Medical treatment after such inappropriate procedures
was difficult.
According to Bolling and colleagues,4 mitral recon-
struction can be performed alone for cardiomyopathy
with significant mitral regurgitation, with a low opera-
tive mortality, although there is a risk of late death and
return of heart failure within 4 years after the operation.
The 2-year actuarial survival in their report was 71%.
This late morbidity is higher in the ischemic group than
the nonischemic group. Therefore, we thought this pro-
cedure might work in a certain type of nonischemic
cardiomyopathy in which mitral regurgitation is caus-
ing left ventricular dilatation with viable myocardium.
By intraoperative echocardiographic assessment,
13 of 29 patients with a dilated left ventricle associ-
ated with mitral regurgitation were thought to be
acceptable for this procedure. The mortality was low
with valve surgery alone, but late follow-up was
needed to see whether the incidence of recurrent
heart failure was reduced or not. In our experience,
2 patients with initial mitral valve reconstruction
have undergone left ventricular reduction because of
recurrent heart failure. With careful follow-up of pa-
tients and analysis of the results, the decision of whether
to perform left ventricular reduction or valvular
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Fig 8.  Phase-image analysis in gated cardiac radioimmunologic scintiscan before and after partial left ven-
triculectomy. No valve reconstruction was combined because the patient did not have significant mitral regurgita-
tion. Ejection fraction (EF) increased from 7% to 31% and 37% at 1 and 6 postoperative months. Histogram
showed improved synchronicity with decreased SD from 80.3 to 22.5 and 15.6 after the operation. New York Heart
Association class improved from IV to I in a 38-year-old man.
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Table III.  Cox proportional hazard model analysis for hospital and late mortality
Variable No. Hazard ratio 95% CL P value
Sex
Female 12 1
Male 74 0.61 0.23-1.61 .3
Mitral regurgitation
Absent 23 1
Present 63 3.34 1.00-11.14 .050
NYHA
III 37 1
IV 49 3.09 1.24-7.69 .02
Operation
Elective 72 1
Emergency 14 7.17 3.20-16.08 <.001
Procedure
EVCPP ± valve 33 1
Group I 24 2.70 1.12-6.53 .03
Group II: LV reduction 16 0.27 0.03-2.20 .2
Group II: Valve alone 13 1.27 0.38-4.22 .7
Age (y)
14-49 29 1
50-61 31 0.94 0.38-2.33 .9
62-74 26 0.79 0.29-4.22 .6
Ejection fraction (%)
4-19 34 1
20-25 27 0.67 0.28-1.62 .4
26-33 22 0.40 0.13-1.24 .11
CL, Confidence limits; NYHA, New York Heart Association; EVCPP, endoventricular circular patch plasty; LV, left ventricular; group I, before induction of volume
reduction test; group II, after induction of volume reduction test.
Fig 9.  Phase-image analysis in patients who had return of heart failure after partial left ventriculectomy. They were
all discharged once with clinical improvement. Note that the postoperative left ventricular diameter (LVDd) is not
always too large. 
reconstruction alone will be made more accurately in
the future.
One useful diagnostic method to predict recurrent heart
failure was a histogram of phase image analysis in gated
cardiac radioimmunologic scintigraphy. Phase image
analysis is known to be a reliable method to assess the
function and conduction of the left ventricle.27,28 In all
examined patients with cardiomyopathy, the histogram
showed a widespread standard deviation due to lack of
synchronicity of the left ventricle. Therefore, cautious
follow-up was necessary and reoperation or listing for
cardiac transplantation was advisable for those patients
with clinical improvement after the operation but no
improvement in the histogram.
Conclusion
1. Ventriculoplasty and valvuloplasty are acceptably
safe and effective treatments for end-stage cardiomy-
opathy with the proper choice of patients and surgical
procedures. 
2. In emergency operations for patients with ongoing
shock, PLV is associated with an extremely high risk.
Treatment with a left ventricular assist device, if avail-
able, should be considered initially. 
3. An echo-guided volume reduction test provides
vital ventricular wall characteristics.
4. Phase image analysis is useful to predict the recur-
rence of heart failure.
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Discussion
Dr Steven F. Bolling (Ann Arbor, Mich). This paper con-
tinues Dr Suma’s good work in geometric restoration of the
left ventricle. Many procedures are being developed in that
area. This paper helps us to make a better choice of which
patient will do well. I have a number of questions for you, Dr
Suma. 
It is clear that this is a mixed series and that you changed
the type of operation, the type of patient, and even how the
operations were performed. Do you think this is reflective of
the learning curve, and do you have these procedures now
crystallized in your mind on how we should all do them?
Second, did you undersize all the mitral rings, as is being
advocated by some? Did all of the patients with mitral regur-
gitation have 4+ regurgitation? 
We would all like to be able to predict which patients will
do well with a given operation, and this manuscript address-
es those concerns. In terms of your volume size test on CPB,
how thick should the myocardium be? Is there a measurement
in millimeters that we should leave in or take out depending
on how thick the myocardium is? How kinetic is kinetic? Is
there an area of dyskinesia that we should leave in hopes that
it will recover, or should we take it out? How do you evaluate
diastolic function during decompressed CPB? How stiff is too
stiff? 
Last, myocyte size and fibrosis are not predictive of out-
come. Were there other markers, perhaps biochemical mark-
ers or neurohormonal markers, that could be used to predict
patient outcome? 
Dr Suma. Thank you very much, Dr Bolling. To answer
your question about procedure change, it certainly was a
result of the learning period. I learned a lot in treating 20 to
30 patients. As you know, when the Batista operation was first
introduced, the idea was simply to make the big heart small,
with no knowledge of viability or extent of myocardial dis-
ease. It was like jumping into the jungle without a map.
Certainly, we have to jump into the jungle to save the patient
with heart failure, but we do need a reliable map. 
Today I mentioned our map, which is still primitive.
However, if we make many maps and put them together, I
think this operation will grow. During the first period in non-
ischemic dilated cardiomyopathy, I found that the extent of
myocardial disease is not homogeneous. Sometimes part of
the posterior wall is diseased, and sometimes part of the sep-
tum. We have to know the extent of the lesion and viability
before selecting the procedure. Therefore, we introduced the
intraoperative echo-guided volume reduction test as a sort of
viability provocation. 
It is impossible to know the actual thickness of the left ven-
tricular wall before the operation, because most of the left
ventricular wall of dilated hearts looks very thin by echocar-
diography. For one thing, it is already fibrotic or just
stretched, but we cannot tell the difference unless we reduce
wall tension. Fortunately, we can do it during the operation
by left ventricular decompression on the pump, and we can
have the information before we cut the left ventricle. Then we
can decide whether to do an annuloplasty alone or whether to
cut somewhere. We always try to insert an undersized ring to
stop mitral regurgitation, as you suggested, regardless of the
degree, not only 4+ regurgitation.
Once we identify the akinetic or dyskinetic area with left
ventricular decompression, we believe this area should be
excised or excluded. However, it is important not to make the
heart too small. 
The Dor operation is the primary choice for ischemic car-
diomyopathy. In ischemic cardiomyopathy, which mostly
results from occlusion of the left anterior descending artery,
the septum is almost always involved. It is advisable to
exclude it, and patch plasty is an effective and easy way. 
Diastolic function is a very difficult problem but very
important. We tried to identify this by the peak filling ratio or
by a time to peak filling by using postoperative radioim-
munoassay scintigraphy. We found a slight trend to indicate
that diastolic function gets better in patients who return to
NYHA class I or II and that it gets worse in patients who have
recurrent heart failure. However, the number is small; I can-
not tell you the final answer.
We could not find any correlation to clinical outcome by
looking at myocytes. A Brazilian group, however, has previ-
ously shown that myocytes are an important predictor. We
still do not know much about it, and we do not have any other
marker to predict the outcome at present. 
Dr Patrick M. McCarthy (Cleveland, Ohio). This is an
interesting and unique report from Dr Suma, because he
describes a variety of operations for a heterogeneous group of
patients with cardiomyopathy. Since the paper includes such
diverse problems as sarcoidosis-induced cardiomyopathy and
arrhythmogenic right ventricular dysplasia, as well as unusu-
al operations such as left ventricular assist device implanta-
tion with tricuspid valve replacement, it is easy to overlook
some of the important fundamental messages. 
The first message is that for elective operations, the mor-
tality was very low; it was 4% for the Dor procedure, 6% for
the Batista operation, and 0% for valve surgery. Second,
short-term and mid-term clinical follow-up and left ventricu-
lar function follow-up showed significant improvement.
Thus, the message is that for patients in stable condition
undergoing elective operations, a variety of interventions can
be safely performed with good initial results. Our job is to
learn how best to apply a variety of operations to a diverse
group of patients with cardiomyopathy.
I have 3 questions. First, in the patients with nonischemic
dilated cardiomyopathy with localized thinning that you see
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by intraoperative echocardiography, how do you handle the
thin-walled left ventricular septum? 
Second, does the long-term management of these patients
postoperatively include intensive heart failure treatment such
as angiotensin-converting enzyme inhibitors, carvedilol, and
amiodarone? Do you give warfarin sodium (Coumadin) to
these patients with left ventricular reconstruction? 
Third, the data on peak filling ratio were intriguing, indi-
cating diastolic dysfunction in the patients in whom heart
failure recurred. Do you have preoperative peak filling data
that might help to predict which patients will not be benefit-
ed by surgery?
Dr Mehmet C. Oz (New York, NY). Dr Suma, excellent
results such as those that you present have captured the imag-
ination of many of the surgeons in the audience. They have
not done the same for our referring cardiologists, and part of
their criticism revolves around our definition of what
“improvement” means. 
In addition to ejection fraction, which many in the cardiol-
ogy group do not acknowledge to indicate improvement, do
we have hemodynamic indexes or other evidence of true
improvement in the ventricular function of these patients over
the long term, including everything from pressure volume
loops to evaluations of wall thickness? You seem to have the
imaging ability to get this information. 
Apropos of the need to convince our referring physicians
that there is something to this operation, or this range of oper-
ations, do we need a randomized trial, either between medical
therapy and the Dor procedure, or perhaps even within a sur-
gical group, to decide whether patients should be getting just
CABG or valve repair with or without a Dor-type operation? 
Dr Suma. Dr McCarthy, you raised a very important tech-
nical point. In the beginning we thought that muscle damage
was almost homogeneous in the nonischemic dilated car-
diomyopathy, but it is not. If the patient has a diseased area in
the septum and anterior myocardium and the surgeon per-
forms the typical Batista operation, which excises the lateral
wall, then the patient will die. In this particular case, it would
be preferable to do the EVCPP to exclude the anterior
myocardium and septum. But it is important to be careful. In
nonischemic disease, the muscle is fragile, and it is not easy
to insert the purse-string stitch and put the patch on. The sur-
geon must think about a different technique, perhaps an inter-
rupted stitch, to fix the patch. We have done this in 3 patients
with nonischemic cardiomyopathy, and all are alive and well,
so far.
To answer the second question, we continue to use the
angiotensin-converting enzyme inhibitor, carvedilol, and
amiodarone after the operation. Interestingly, in some cases
we found that those drugs are easier to use after the operation.
Finally, I do not have any data regarding use of diastolic
function as a preoperative parameter to predict outcome,
because it is very variable. Until we understand the diastolic
function more clearly, it will be difficult to make it a single
predictor for outcome. 
Dr Oz, ejection fraction provides no information to help the
cardiologists understand how the patient gets better. The most
striking parameter is clinical status. We often see that the
ejection fraction rose 5% but the patient’s clinical status has
risen from class IV to class II or I. Pressure volume loop, car-
diac output, and the oxygen consumption are also important
parameters. 
It was impossible to conduct a randomized trial because at the
time of this study we could not reliably predict good results
with left ventricular reduction. Now the situation has stabilized.
If someone wants to conduct a randomized trial now, it may be
possible to do it. However, it seems to be really difficult to ran-
domize for the experts. If you send the patient to Dr Dor, he
may always do the Dor operation. If you send the patient to Dr
Bolling, he may never touch the left ventricle. It may be that a
randomized trial can be done only by someone else, who can
learn every technique at a high level.
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